­
Archive by Author

Avastin and cost effectiveness

I can’t understand the blame being apportioned in press coverage over NICE’s decision not to fund Avastin, or bevacizumab, for the treatment of advanced bowel cancer. Many patients groups are laying the blame with NICE. Is this fair? The important bit to me is ‘cost effectiveness’. It isn’t about either cost or effectiveness alone. While […]

Continue Reading →

Religious doctors and death

A paper in the Journal of Medical Ethics is suggesting that non religious doctors “were more likely than others to report having given continuous deep sedation until death, having taken decisions they expected or partly intended to end life” . This seems to have caused some furore on Radio 4 this am with a discussion about whether […]

Continue Reading →

Sense on genetic screening from the USA

Great to see some straight talking common sense from the US. Just because you can have your genome dissected, doesn’t mean you should pay a few hundred pounds for your ‘genetic risk assessment’ as several UK and US websites currently offer. These tests may need FDA approval, says this piece from the New England Journal of […]

Continue Reading →

Is UK cancer survival so bad?

The idea that the UK is a bad place to get treated as cancer seems to have been accepted as truth by certain sections of the media. It just isn’t : I’ve been trying to say so for a while with no success whatsoever. Anyway this editorial in the BMJ looks at the reliablity of […]

Continue Reading →

The Kings Fund on GP referral management centres

I’m not quite sure what I think of the King’s Fund: some of their papers seem to me to miss the point: academic distance from reality can be damaging. They have examined Referral Management Centres and concluded that they aren’t very good, which was obvious to GPs but lost on politicians. Quite interesting. What I […]

Continue Reading →